79 results
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
was adopted by a special resolution on September 23, 2019. Prior to such date, we granted options under a prior employee share option plan, which had the same … and conditions of new grants are as follows, whereby all options are settled by physical delivery of shares:
Vesting conditions
The employee share
6-K
EX-99.5
AMYT
Amryt Pharma Plc
4 Aug 22
Results of Annual General Meeting
7:38am
was adopted by a special resolution on September 23, 2019. Prior to such date, we granted options under a prior employee share option plan, which had the same … and conditions of new grants are as follows, whereby all options are settled by physical delivery of shares:
Vesting conditionsThe employee share options
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
5:06pm
executive officer’s compensation to median employee compensation.
We may choose to take advantage of some but not all of these exemptions. For example
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
4:58pm
shares and employee option holders prior to the acquisition of Aegerion Pharmaceuticals, Inc., assuming all relevant milestones are achieved;
up … is not an officer or employee of the Company (or of any related company) and has not (and is not deemed to have) acquired the ADSs by reason of an office
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
4:57pm
and employee option holders prior to the acquisition of Aegerion Pharmaceuticals, Inc., assuming all relevant milestones are achieved;
up … schemes, charities or tax-exempt organizations, (d) assumes that the holder is not an officer or employee of the Company (or of any related company
F-3
EX-5.1
0ol crhf0vq4aoc
11 May 22
Shelf registration (foreign)
5:22pm
F-3
kr6i4u5v
11 May 22
Shelf registration (foreign)
5:22pm
POS AM
ijeavqgjx3o4pd16zsyi
11 May 22
Prospectus update (post-effective amendment)
5:20pm
POS AM
sx3scw f8v
11 May 22
Prospectus update (post-effective amendment)
5:19pm
6-K
EX-99.2
mgg7i
11 May 22
Current report (foreign)
4:30pm
424B3
xvzp9stw
4 May 22
Prospectus supplement
8:35am
424B3
zp8aoytl
4 May 22
Prospectus supplement
7:45am
6-K
EX-99.1
z2dcgknitgn66flwvbq
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am